Atlas Trials

Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis

Clinical trial NCT04762953 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04762953
Sponsor
University of California, Irvine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerPeritoneal CarcinomatosisGastroesophageal Junction Adenocarcinoma
Start date
2021-02-18
Primary completion
2026-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.